Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Filtros aplicados
Base de dados
Intervalo de ano de publicação
1.
Journal of clinical microbiology, ; 46(10): 3426-3428, Oct 2008. tab
Artigo em Inglês | MedCarib | ID: med-17729

RESUMO

The rapid identification of drug-resistant strains of Mycobacterium tuberculosis is crucial for the timely initiation of appropriate antituberculosis therapy. The performance of the Genotype MTBDRplus assay was compared with that of the Bactec 460 TB system, a "gold standard" culture-based method. The Genotype MTBDRplus assay was quicker and more cost-effective for the detection of rifampin resistance, but it was not as good for the detection of isoniazid-resistant strains in our setting.


Assuntos
Humanos , Mycobacterium tuberculosis , Isoniazida , Rifampina , Índias Ocidentais , Trinidad e Tobago
2.
London; British Leprosy Relief Association; s.d. 288-99 p. tab.
Monografia em Inglês | MedCarib | ID: med-4402

RESUMO

Multidrug therapy consisting of rifampicin, clofazimine and dapsone, was introduced to Trinidad and Tobago in January 1982. This was with slight modification of the WHO regimens. Since then 717 patients have completed multidrug therapy up to the end of December 1987. Of these, 272 patients have completed surveillance and have been discharged from clinic attendance. Thirty-four patients died before completing surveillance and three are known to have migrated. Of the remaining 408 cases still under surveillance, the majority are multibacillary. This paper reviews the outcome of multidrug therapy in Trinidad and Tobago between January 1982 and December 1987 - a period of 6 years, and presents some of the statistics related to the newly diagnosed patients within the same period. (AU)


Assuntos
Humanos , Hanseníase/tratamento farmacológico , Rifampina/administração & dosagem , Rifampina/uso terapêutico , Clofazimina/administração & dosagem , Clofazimina/uso terapêutico , Dapsona/administração & dosagem , Dapsona/uso terapêutico , Trinidad e Tobago
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...